CIK: 0001388551 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 15, 2016
Total Value ($000): $88,642 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CELATOR PHARMACEUTICALS INC | 2,232,272 | $67,370 | 76.0% | $3.51 | — | COM | 15089R102 |
| — | AGILE THERAPEUTICS INC | 1,580,491 | $12,028 | 13.6% | $6.37 | — | COM | 00847L100 |
| — | SYNTA PHARMACEUTICALS CORP | 21,770,662 | $5,665 | 6.4% | $6.65 | — | COM | 87162T206 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 8,945 | $1,295 | 1.5% | $132.86 | +7.6% | CL B NEW | 084670702 |
| CSW | CSW INDUSTRIALS INC | 11,253 | $367 | 0.4% | $30.96 | +1.7% | COM | 126402106 |
| SCM | STELLUS CAP INVT CORP | 29,728 | $304 | 0.3% | $10.51 | -3.6% | COM | 858568108 |
| — | CM FIN INC | 33,247 | $295 | 0.3% | $9.30 | — | COM | 12574Q103 |
| — | PARATEK PHARMACEUTICALS INC | 18,909 | $263 | 0.3% | $13.91 | — | COM | 699374302 |
| DOV | DOVER CORP | 3,224 | $223 | 0.3% | $40.98 | +11.9% | COM | 260003108 |
| — | CIDARA THERAPEUTICS INC | 18,807 | $194 | 0.2% | $14.99 | — | COM | 171757107 |
| — | MEDLEY CAP CORP | 24,913 | $167 | 0.2% | $8.19 | — | COM | 58503F106 |
| — | AMERICAN CAP SR FLOATING LTD | 15,255 | $157 | 0.2% | $9.84 | — | COM | 02504D108 |
| — | GARRISON CAP INC | 15,104 | $152 | 0.2% | $10.06 | — | COM | 366554103 |
| — | STRONGBRIDGE BIOPHARMA PLC | 35,977 | $143 | 0.2% | $3.97 | — | SHS USD | G85347105 |
| — | SYNTA PHARMACEUTICALS CORP | 72,000 | $19 | 0.0% | $6.65 | — | Call | 87162T206 |